HRT – it’s good for the heart

29th November 2012 by Louise Hudman

This article from the BMJ on the effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women was bought to my attention by a member who felt that its message was important for all of us to see, given recent safety concerns about HRT use.

1006 healthy, white women were selected. They were either recently (within 2 yrs) postmenopausal, or were peri-menopausal. They were aged 45 to 58. They were randomly allocated to either receiving HRT (cases), or not (controls). HRT used was triphasic, or oestradiol alone if they had no uterus. The composite ‘primary endpoint’ was death, admission to hospital for heart failure and MI. The study was stopped after 10 yrs because of safety concerns from other studies.

After 10 years, significantly fewer cases experienced the ‘primary endpoint’ than controls (hazard ratio 0.48, 3% cases vs 6.5% controls). This was not associated with a significant increase in any cancer, breast cancer, DVT nor stroke. At 16 years, there was still a reduction in the primary composite endpoint.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I started working as a locum GP in January this year and NASGP have been invaluable in helping to co-ordinate my bookings and organise all the administrative aspects of sessional work which can be complex and time consuming. Their client support is outstanding and they have always resolved any queries promptly and personally. They care about the service they provide and I would not hesitate to recommend them to any sessional GPs who want to minimise time spent on administration and focus on providing patients with high quality care."

Dr Paul Riley, Locum GP

Dr Paul Riley, Locum GP

See the full list of features within our NASGP membership plans

Membership